Doctor-supervised program brings prescription weight loss medications within reach for millions of Americans

If you've been following the weight loss revolution sweeping across America, you've heard the names: Ozempic. Wegovy. Semaglutide. Tirzepatide.

These GLP-1 medications have become household names because they actually work. Clinical studies show average weight loss of 15-20% of body weight. That's not a typo—we're talking about real, substantial weight loss that changes lives.

There's just one problem: most Americans can't afford them.

Brand-name Ozempic and Wegovy can cost $1,000 to $1,400 per month. Even worse, most insurance companies won't cover them for weight loss. They'll cover them for diabetes, but if you simply want to lose weight and improve your health? You're on your own.

For the past two years, these medications have been the exclusive domain of celebrities, executives, and the wealthy. Regular Americans have watched from the sidelines as Hollywood transformed, while their own weight loss struggles continued.

But something has changed in the past few months—and it's creating an opportunity for millions of people who thought these medications were forever out of reach.

The Telehealth Revolution Meets Compound Medications

Here's what most people don't understand: compound medications contain the same active ingredients as their brand-name counterparts but are produced by specialized compounding pharmacies. This is completely legal, FDA-regulated, and has been standard practice in American medicine for decades.

When it comes to GLP-1 medications, compound versions can cost a fraction of the brand-name price—sometimes 80-90% less.

New online medical platforms are now Connecting Patients Directly with Licensed Physicians who can evaluate candidates for GLP-1 medications, write prescriptions for compound versions, and provide ongoing medical supervision—all without expensive in-person clinic visits.

One such program gaining significant attention is Medvi, a telehealth platform making physician-supervised GLP-1 medications accessible to regular Americans at budget-friendly prices.

How the Process Works

You complete a comprehensive health questionnaire online. A licensed physician reviews your information and evaluates whether you're a good candidate for GLP-1 medications.

If approved, the physician writes a prescription for compound semaglutide or tirzepatide and sends it directly to a partnered compounding pharmacy. The medication ships directly to your door with complete administration instructions.

Throughout your journey, you have access to ongoing physician oversight. You're not just buying medication online—you're entering a legitimate medical weight loss program with real doctor supervision.

You can See if You Qualify for Medvi’s Program Here.

Who These Programs Are Designed For

These programs are designed for adults aged 21-80 who are overweight or obese and who have struggled with traditional diet and exercise approaches. The medications work by mimicking a hormone that regulates appetite and blood sugar, essentially reducing hunger and helping you feel full with less food.

The Investment

While brand-name Ozempic and Wegovy cost $1,000-$1,400 monthly, compound GLP-1 programs like Medvi start at 90% less. This includes the physician evaluation, prescription, medication, and shipping.

No insurance required. No pre-authorization hassles. You pay directly, and the medication ships directly to you.

To learn more about Medvi's physician-supervised GLP-1 program and see if you qualify, Learn More about the Program Here.